GlaxoSmithKline Extends Use of InforSense Platform | GenomeWeb

GlaxoSmithKline Extends Use of InforSense Platform

Jul 28, 2008

NEW YORK (GenomeWeb News) – InforSense said on Friday that GlaxoSmithKline has signed a contract to continue using the firm’s InforSense platform for another three years.

The London-based firm said that around 800 users within the drug giant are currently using the platform, which is a workflow-management software tool.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.